HMGN1 and neoplasm: Zuo et al. modified tumor-derived EVs with the functional domain of HMGN1 via an anchor peptide, and DCs pulsed by these modified EVs show long-term anti-tumor immunity and tumor inhibition effect by enhancing memory T cell response (Zuo et al., 2020).